Non-Vitamin K Oral Anticoagulants Versus Warfarin for Patients With Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights

Cardiovascular Therapeutics - United Kingdom
doi 10.1111/1755-5922.12173

Related search